Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Chemoembolization of Hepatocellular Carcinoma.

about

Heterogeneity analysis of triphasic CT scan perfusion parameters in differential diagnosis of hepatocellular carcinoma and hemangioma

P2860

Q58704241-C823F174-528A-4138-BF2C-2756765166D7

P2860

Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Chemoembolization of Hepatocellular Carcinoma.

Item

http://www.wikidata.org/entity/Q55128321

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@en

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@nl

type

Item

label

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@en

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@nl

prefLabel

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@en

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@nl

P1476

Computed Tomographic Perfusion ...... n of Hepatocellular Carcinoma.

@en

P2093

Ana Leban

http://www.w3.org/2001/XMLSchema#string

Klara Kregar

http://www.w3.org/2001/XMLSchema#string

Manca Garbajs

http://www.w3.org/2001/XMLSchema#string

Matjaz Bunc

http://www.w3.org/2001/XMLSchema#string

Peter Popovic

http://www.w3.org/2001/XMLSchema#string

Rok Dezman

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostication and response assessment in liver and pancreatic tumors: The new imaging

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data.

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

CT perfusion of the liver: principles and applications in oncology.

Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck.

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

P304

14-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/RAON-2017-0052

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29520201

http://www.w3.org/2001/XMLSchema#string

P932

5839077

http://www.w3.org/2001/XMLSchema#string

Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Chemoembolization of Hepatocellular Carcinoma.

about

P2860

P2860

Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Chemoembolization of Hepatocellular Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932